DGX — QUEST DIAGNOSTICS INC
—
NYSE ·
Health Care ·
Health Care Providers & Services ·
CIK 1022079 ·
Last close
$237.62
Market Cap
$26.23B
52W High
$248.84
52W Low
$168.97
ADV30
1,030,125
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 3,043,000,000 | 1,027,000,000 | 459,000,000 | 320,000,000 | 16,939,000,000 | 626,000,000 | 9,040,000,000 |
| Mar 2026 | 2,895,000,000 | 942,000,000 | 404,000,000 | 252,000,000 | 16,673,000,000 | 393,000,000 | 8,928,000,000 |
| Dec 2025 | 2,806,000,000 | 910,000,000 | 386,000,000 | 245,000,000 | 16,225,000,000 | 420,000,000 | 8,939,000,000 |
| Sep 2025 | 2,816,000,000 | 949,000,000 | 386,000,000 | 245,000,000 | 16,197,000,000 | 432,000,000 | 8,821,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,903,000,000
Investing CF
$-678,000,000
Financing CF
$-915,000,000
CapEx
$-554,000,000
Dividends Paid
$-363,000,000
Buybacks
$-450,000,000
EPS Diluted TTM
$9.42
As of
2026-07-26
Balance + Analyst (yfinance extras)
Retained Earnings
$10,374,000,000
Inventory
$233,000,000
Receivables
$1,666,000,000
ST Investments
—
EBIT TTM
$1,673,000,000
Pretax Income TTM
$1,404,000,000
Interest Exp TTM
$269,000,000
Analysts
16
Yahoo Snapshot (yfinance, live)
Total Revenue
$11,559,999,488
EBITDA
$2,265,999,872
Free Cash Flow
$909,625,024
Enterprise Value
$32,100,947,968
Total Cash
$626,000,000
Total Debt
$6,403,999,744
Shares Out
110,373,360
Trailing EPS
$9.42
Book Value
$68.33
ROE
14.6%
ROA
6.4%
Div Yield
1.46%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 11,035,000,000 | 1,556,000,000 | 992,000,000 | 16,225,000,000 | 8,939,000,000 | 7,170,000,000 | 1,886,000,000 |
| Dec 2024 | 9,872,000,000 | 1,346,000,000 | 871,000,000 | 16,153,000,000 | 9,257,000,000 | 6,778,000,000 | 1,334,000,000 |
| Dec 2023 | 9,252,000,000 | 1,262,000,000 | 854,000,000 | 14,022,000,000 | 7,604,000,000 | 6,307,000,000 | 1,272,000,000 |
| Dec 2022 | 9,883,000,000 | 1,428,000,000 | 946,000,000 | 12,837,000,000 | 6,830,000,000 | 5,893,000,000 | 1,718,000,000 |
TTM Snapshot
Revenues TTM
$9,921,000,000
NetIncome TTM
$927,000,000
OpCashFlow TTM
$0
Assets (Latest)
$16,225,000,000
Forward EPS
$12.06
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LH | LABCORP HOLDINGS INC. | $25.11B | $309.57 | — |
| GH | Guardant Health, Inc. | $23.80B | $177.33 | — |
| THC | TENET HEALTHCARE CORP | $20.77B | $257.93 | — |
| EHC | Encompass Health Corp | $12.23B | $124.02 | — |
| FMS | Fresenius Medical Care AG | $12.21B | $22.95 | — |
News headlines (Yahoo Finance, 1h cache)
Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally?
2026-09-25 11:14 · Yahoo
Quest Diagnostics (DGX) Could Be 5% Below Fair Value After Apple Health Launch
2026-09-23 17:13 · Yahoo
Why Quest Diagnostics Holdings Stock Dropped Today
2026-09-22 15:57 · Yahoo
NICU Genetic Testing Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)
2026-09-22 15:54 · Yahoo
Quest Diagnostics Study Finds High Tick-Borne Disease Co-Exposure
2026-09-22 14:00 · Yahoo
Quest Diagnostics, Labcorp Shares Fall as Medicare Signals Cuts in Payment Rates for Lab Services
2026-09-22 12:46 · Yahoo
Is This the Right Time to Add DGX Stock to Your Portfolio?
2026-09-22 12:28 · Yahoo
Is Quest Diagnostics Stock Outperforming the Nasdaq?
2026-09-22 11:56 · Yahoo
Premarket movers: Quest, Labcorp hit by CMS cuts
2026-09-22 11:55 · Yahoo
Quest Diagnostics Sees Growth Outpace Targets as Consumer Testing Surges
2026-09-21 14:02 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.